Alzheimer's disease (AD) is a neurodegenerative disease characterized by amyloid plaques
and neurofibrillary tangles which significantly affects people's life quality. Recently, AD has …

Alzheimer's disease (AD) is a neurodegenerative disease with an annual incidence
increase that poses significant health risks to people. However, the pathogenesis of AD is …

Alzheimer's disease (AD) is a neurodegenerative disorder characterized primarily by a
decline in cognitive function. However, the etiopathogenesis of AD is unclear. N6 …

Myocyte enhancer factor 2C (MEF2C) is highly expressed in the nervous system, and
regulates neuro-development, synaptic plasticity, and inflammation. However, its …

Alzheimer's disease (AD) is a common neurodegenerative disease. The concealment of the
disease is the difficulty of its prevention and treatment. Previous studies have shown that …

Alzheimer's disease, the most common form of dementia in the elderly, is a kind of
neurodegenerative disease. However, its pathogenesis and diagnosis remain unclear. M6A …

Neuroinflammation and autophagy dysfunction are closely related to the development of
neurodegeneration such as Parkinson's disease (PD). However, the role of autophagy in …

Oxidative stress has been implicated in both normal aging and various neurodegenerative
disorders and it may be a major cause of neuronal death. Chaperone-mediated autophagy …

Alzheimer's disease (AD) is characterized by the abnormal deposition of amyloid-β (Aβ)
plaques and tau tangles in the brain and accompanied with cognitive impairment. However …

The myocyte enhancer factor (MEF2) family of transcription factors plays a vital role in
memory and learning due to its functions in regulating synapse number and reducing …